Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingyu Zhou

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Current Drug Metabolism|October 27, 2005
Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymesQingyu Zhou, Shufeng Zhou, Eli Chan
The Journal of Pharmacology and Experimental Therapeutics|October 13, 2017
Activation of Focal Adhesion Kinase and Src Mediates Acquired Sorafenib Resistance in A549 Human Lung Adenocarcinoma XenograftsQingyu Zhou, Xiaofang Guo, Riya Choksi
Current Drug Metabolism|April 28, 2005
Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomesQingyu Zhou, Shufeng Zhou, Eli Chan
Cancers|October 18, 2019
Molecular Insights into Potential Contributions of Natural Polyphenols to Lung Cancer TreatmentQingyu Zhou, Hua Pan, Jing Li
Electrophoresis|August 6, 2003
Enantioseparation of warfarin and its metabolites by capillary zone electrophoresisQingyu Zhou, Wai-Ping Yau, Eli Chan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomideQingyu Zhou, Ping Guo, James M Gallo
Molecular Cancer Therapeutics|June 11, 2009
Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinibShining Wang, Qingyu Zhou, James M Gallo
Clinical and Experimental Pharmacology & Physiology|January 17, 2016
Multifaceted ability of naturally occurring polyphenols against metastatic cancerQingyu Zhou, Lunawati L Bennett, Shufeng Zhou
BMC Medical Research Methodology|March 28, 2026
A unified framework for complex survival data: accounting for clustering, cure fractions, and competing risksYijun Wang, Jie Li, Qingyu Zhou, et al.
Public Health in Practice (Oxford, England)|January 21, 2025
The application of One Health concept in China and its practice and innovation in cross-sector cooperationYang Gao, Chengyue Li, Qingyu Zhou, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Current Drug Metabolism|October 27, 2005
Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymesQingyu Zhou, Shufeng Zhou, Eli Chan
The Journal of Pharmacology and Experimental Therapeutics|October 13, 2017
Activation of Focal Adhesion Kinase and Src Mediates Acquired Sorafenib Resistance in A549 Human Lung Adenocarcinoma XenograftsQingyu Zhou, Xiaofang Guo, Riya Choksi
Current Drug Metabolism|April 28, 2005
Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomesQingyu Zhou, Shufeng Zhou, Eli Chan
Cancers|October 18, 2019
Molecular Insights into Potential Contributions of Natural Polyphenols to Lung Cancer TreatmentQingyu Zhou, Hua Pan, Jing Li
Electrophoresis|August 6, 2003
Enantioseparation of warfarin and its metabolites by capillary zone electrophoresisQingyu Zhou, Wai-Ping Yau, Eli Chan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomideQingyu Zhou, Ping Guo, James M Gallo
Molecular Cancer Therapeutics|June 11, 2009
Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinibShining Wang, Qingyu Zhou, James M Gallo
Clinical and Experimental Pharmacology & Physiology|January 17, 2016
Multifaceted ability of naturally occurring polyphenols against metastatic cancerQingyu Zhou, Lunawati L Bennett, Shufeng Zhou
BMC Medical Research Methodology|March 28, 2026
A unified framework for complex survival data: accounting for clustering, cure fractions, and competing risksYijun Wang, Jie Li, Qingyu Zhou, et al.
Public Health in Practice (Oxford, England)|January 21, 2025
The application of One Health concept in China and its practice and innovation in cross-sector cooperationYang Gao, Chengyue Li, Qingyu Zhou, et al.
Pageof 9